Suppression of Docetaxel induced apoptosis in Survivin-depleted cells due to failure of sustained mitotic block

Abstract

The antitumor effect of taxanes have been attributed to their ability to induce mitotic arrest through activation of the spindle assembly checkpoint. Cell death following prolonged mitotic arrest is mediated by the intrinsic apoptosis pathway. Accordingly, factors that influence the robustness of mitotic arrest or disrupt the apoptotic machinery might confer drug resistance. Survivin is an inhibitor of apoptosis protein. Its overexpression has been associated with resistance to multiple anticancer agents including taxanes, and its targeting led to drug sensitization. On the other hand, Survivin is a key regulator of mitosis, which is shown to be required for stable activation of the spindle assembly checkpoint. Since the sensitivity of taxanes depends on a functional spindle checkpoint, inhibition of Survivin may lead to drug resistance, which is the opposite effect of its anti-apoptotic function. Here we show that Survivin-depleted cells escape the mitotic block following Docetaxel treatment, thereby evading drug induced apoptosis. Moreover, Survivin depletion increases the level of mitotic catastrophe and cellular senescence induced by Docetaxel and enhanced its efficacy against clonogenic survival of tumor cells. Our finding suggests that inhibition of Survivin promotes non-apoptotic mechanisms following Docetaxel treatment rather than increases the sensitivity of apoptosis.